Cancer-related DNA changes may appear in blood years before diagnosis

The Medical News ·
Health & Medicine United Kingdom

Researchers found that genome-wide plasma cfDNA methylation profiles collected before diagnosis contained early molecular signatures associated with future prostate and breast cancer, with prostate silencer methylation providing the stronger risk stratification. Breast enhancer signals were weaker and varied by subtype and disease stage, indicating that cfDNA methylation may have greater value…

Read original article on The Medical News →

Related news